Pharmacogenetics and pharmacogenomics: A clinical reality

Roberta Ferraldeschi; William G. Newman

doi:10.1258/acb.2011.011084

Pharmacogenetics and pharmacogenomics: A clinical reality

Research output: Contribution to journal › Article › peer-review

Abstract

Pharmacogenetics and pharmacogenomics strive to explain the interindividual variability in response to drugs due to genetic variation. For certain drugs, genetic tests can reduce adverse drug reactions and improve treatment efcacy. In this review, we will briey consider some successful tests introduced into clinical practice and potential future developments.

Original language	English
Pages (from-to)	410-417
Number of pages	7
Journal	Annals of Clinical Biochemistry
Volume	48
Issue number	5
DOIs	https://doi.org/10.1258/acb.2011.011084
Publication status	Published - Sept 2011

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1258/acb.2011.011084

http://acb.rsmjournals.com/content/48/5/410.full.pdf

Cite this

@article{eb0190330a6e4ca2bbb3ca2879ef49a6,

title = "Pharmacogenetics and pharmacogenomics: A clinical reality",

abstract = "Pharmacogenetics and pharmacogenomics strive to explain the interindividual variability in response to drugs due to genetic variation. For certain drugs, genetic tests can reduce adverse drug reactions and improve treatment efcacy. In this review, we will briey consider some successful tests introduced into clinical practice and potential future developments.",

author = "Roberta Ferraldeschi and Newman, {William G.}",

year = "2011",

month = sep,

doi = "10.1258/acb.2011.011084",

language = "English",

volume = "48",

pages = "410--417",

journal = "Annals of Clinical Biochemistry",

issn = "1758-1001",

publisher = "Sage Publications Ltd",

number = "5",

}

TY - JOUR

T1 - Pharmacogenetics and pharmacogenomics: A clinical reality

AU - Ferraldeschi, Roberta

AU - Newman, William G.

PY - 2011/9

Y1 - 2011/9

N2 - Pharmacogenetics and pharmacogenomics strive to explain the interindividual variability in response to drugs due to genetic variation. For certain drugs, genetic tests can reduce adverse drug reactions and improve treatment efcacy. In this review, we will briey consider some successful tests introduced into clinical practice and potential future developments.

AB - Pharmacogenetics and pharmacogenomics strive to explain the interindividual variability in response to drugs due to genetic variation. For certain drugs, genetic tests can reduce adverse drug reactions and improve treatment efcacy. In this review, we will briey consider some successful tests introduced into clinical practice and potential future developments.

U2 - 10.1258/acb.2011.011084

DO - 10.1258/acb.2011.011084

M3 - Article

C2 - 21733927

SN - 1758-1001

SN - 0004-5632

VL - 48

SP - 410

EP - 417

JO - Annals of Clinical Biochemistry

JF - Annals of Clinical Biochemistry

IS - 5

ER -

Pharmacogenetics and pharmacogenomics: A clinical reality

Abstract

UN SDGs

Access to Document

Fingerprint

Cite this